Ticker
URGNCompany Name
UROGEN PHARMA LTDSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Inventory | Current Liabilities | Quick Ratio |
---|---|---|---|---|
6/30/2025 | $ 196.87M | $ 7.13M | $ 47.55M | 3.99 |
3/31/2025 | $ 237.18M | $ 7.59M | $ 42M | 5.47 |
12/31/2024 | $ 276.13M | $ 9.23M | $ 45.95M | 5.81 |
9/30/2024 | $ 295.1M | $ 7.59M | $ 32.79M | 8.77 |
6/30/2024 | $ 278.97M | $ 7.44M | $ 34.22M | 7.93 |
3/31/2024 | $ 196.76M | $ 7.24M | $ 26.34M | 7.2 |
12/31/2023 | $ 169.19M | $ 5.67M | $ 31.21M | 5.24 |
9/30/2023 | $ 182.12M | $ 5M | $ 25.79M | 6.87 |
6/30/2023 | $ 81.33M | $ 4.99M | $ 26.77M | 2.85 |
3/31/2023 | $ 95.97M | $ 5.47M | $ 25.23M | 3.59 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(AssetsC - Inventory) / LiabilitesC
(=) Quick Ratio
Quick Ratio for UROGEN PHARMA LTD is calculated as follows: (AssetsC [ $ 129.34M ] - Inventory [ $ 1.35M ]) / LiabilitesC [ $ 17.62M ]
(=) Quick Ratio [ 7.26 ]
Minimum
Jun 30, 2023
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 3.12K |
---|---|
min | -0.73 |
max | 5.45 |
average | 1.55 |
median | 1.23 |
std | 1.17 |